sxtchina.com (SXTC) Company Sales Revenue

Corporate emblem and logo of SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals (SXTC) is subject to PRC regulatory norms and the risks of delisting from US exchanges. The company's current sales dynamics clearly illustrate these fluctuations, with the value of 0.00 serving as the current metric. While some packaging processes are automated, raw material preparation remains manual. Intense price competition with local networks complicates the wholesale trade of traditional remedies.

Revenue and Sales Volume: sxtchina.com (SXTC) for 07/04/2022 - 11/17/2026

Analytical breakdowns for China SXT Pharmaceuticals

- market price and analyst price targets:
Summary company analysis:SXTC, SXT China
Manufactured product of sxtchina.com

Revenue for China SXT Pharmaceuticals (SXTC) reflects actual cash flow, confirming distribution efficiency and compliance with KTM standards. This metric measures the daily volume of products sold to assess asset liquidity. By analyzing the company's sales dynamics, an investor can identify demand peaks or risks of capital stagnation. This indicator links production line capacity with market sales. The steady growth of the curve confirms the business's resilience to government regulation.

Competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|TNXP (tonixpharma.com) - Revenue and Sales Volume|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP